Clinical effects and safety of interventional therapy for parenchyma vascular malformation.

Parenchyma vascular malformation (VM) is a common disease in modern society. Here, we investigated the clinical effects and safety of interventional therapy (IT) on the treatment of parenchyma VM. From January 1998 to December 2010, 31 patients with VM who elected IT were investigated, including 11 cases of venous VM and 20 cases of arteriovenous malformation. There were 19 males and 12 females, ranging from 12 to 51 years in age. VM often occurred in the four limbs and other areas, such as the trunk and reproductive organs. Under the guidance of digital subtraction angiography, vascular hardener was injected into the VM spot via percutaneous puncture. Then, embolotherapy was conducted via the transcatheter feeding artery. We found that, in all cases, the malformed vessels were completely or partially blocked. After treatment, the local swelling of vessels was alleviated and the diabrosis and bleeding ceased. The soft tissue lump shrank, then stiffened and became fixed. There was no occurrence of severe intraoperative or postoperative complications in any patient. In summary, IT is an effective method for treating parenchyma VM, causes only a minor operative wound, and should be viewed as the first choice intervention.

CT and MR characteristics of cerebral sparganosis.

BACKGROUND AND PURPOSE: Sparganosis is a rare parasitic infection in humans by a larval cestode of the genus Spirometra. Preoperative diagnosis of cerebral sparganosis in the past has been very difficult. Our objective was to evaluate the CT and MR features of cerebral sparganosis in order to make a definite diagnosis. MATERIALS AND METHODS: We retrospectively reviewed 25 patients (13 male and 12 female; age range, 9-83 years) who proved to have cerebral sparganosis. Fifteen patients underwent MR imaging: 2 patients had CT scanning, and the remaining 8 had both CT and MR scanning. We focused on evaluating the imaging features on CT and MR. RESULTS: All patients showed edema and degeneration of cerebral white matter. All but 1 had a unilateral lesion. Twenty-two patients had ipsilateral ventricular dilation. The new finding was a tunnel sign, approximately 4 cm in length and 0.8 cm in width, column or fusiform shaped on postcontrast coronal and sagittal MR images (n = 10). Thirteen patients showed bead-like enhancement, but solitary ring enhancement was common on the CT images (n = 2). The wall of the ring and tunnel appeared isointense or slightly hyperintense on T2-weighted images. Punctate calcifications were seen in 6 patients on CT images but only in 3 patients on the MR images. Hemorrhage was seen in 4 patients on the MR images. An intact whitish, stringlike, living worm was found (n = 5). CONCLUSION: The most characteristic finding was a tunnel sign on postcontrast MR images. The most common finding was bead-shaped enhancement. MR is superior to CT in demonstrating the extent and number of lesions, except punctate calcifications. Combined with clinical data and enzyme-linked immunosorbent assay, the preoperative diagnosis of cerebral sparganosis could be established on MR imaging.